title: Clinical and ethical issues in the diagnosis of hereditary breast cancer (review).
abstract: A small subset of breast and ovarian cancers is related to the mutation of dominant susceptibility genes. The recent isolation of BRCA1 and BRCA2 has created great interest and expectations among members of families with a positive history for breast/ovarian cancer. We reviewed the literature to explore the clinical implications of genetic testing for BRCA1 and BRCA2 mutations among high risk women. Both the value of the information provided by the test and the efficacy of the preventive and diagnostic measures presently available have been examined. We also specifically address the issue of ethical dilemmas arising from widespread availability of genetic information, including psycological reactions of those who receive the test, genetic discrimination by health insurance companies or employers and prenatal testing for BRCA1 mutations.
authors.affiliation: HARTWELL LAB,CANC RES INST,LONDON SW3 6JJ,ENGLAND.
authors.forename: R
authors.initials: R
authors.lastname: Ponzone
authors.forename: M
authors.initials: M
authors.lastname: Giai
authors.forename: R
authors.initials: R
authors.lastname: Roagna
authors.forename: L
authors.initials: L
authors.lastname: Sgro
authors.forename: N
authors.initials: N
authors.lastname: Biglia
authors.forename: H
authors.initials: H
authors.lastname: Welch
authors.forename: P
authors.initials: P
authors.lastname: Sismondi